Andre Watson's Interviews
S3-E2: Andre Watson: Personalized Medicine, Our Antidotal Future
Andre Watson is Founder, Chairman, and CEO of Ligandal, an industry pioneer in precision genetic medicine. Andre has a background in biomedical engineering and is using his knowledge of nanomaterials to develop next-generation technologies for personalized gene therapy with the ultimate goal of curing chronic illnesses
Interview with Andre Watson, Newport Conference, July 18-20, 2022
Interview with Andre Watson, Newport Conference, July 18-20, 2022 You can subscribe to various 361 events and content at https://361firm.com/subs. For reference: Web: www.361firm.com/homeOnboard as Investor: https://361.pub/shortdiagOnboard Deals 361: www.361firm.com/onbOnboard as Banker: www.361firm.com/bankersEvents:
Podcasts with Andre Watson
Possible Pairings
You might also be interested in
Mark Sanor
Investor
Denise Brouder
Entrepreneur
Jim Hawk
Investor
Anna Haskell
Entrepreneur
Matthew Putman
Interview host
KMO
Artist
Stephen Wolfram
Computer scientist
Joscha Bach
Cognitive scientist
Joshua Wilson
Interview host
Nicole Enslein
Business executive
Lee Smolin
Physicist
Dave Gardner
Multimedia Producer
Shout-outs
Add shout-out